We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AVDL market cap is 792.36M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 19.45M | 27.18M | 41.5M | 50.03M | 50.41M |
| Operating Income | -135.3M | -26.04M | -12.74M | -326k | -3.3M |
| Net Income | -28.79M | -27.34M | -13.82M | -2.63M | -5.04M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 68.14M | 53k | 0 | 27.96M | 169.12M |
| Operating Income | 4.55M | -85.55M | -98.56M | -137.85M | -42.4M |
| Net Income | 7.03M | -77.33M | -137.46M | -160.28M | -48.83M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 164.7M | 167.9M | 157.52M | 158.25M | 164.24M |
| Total Liabilities | 76.96M | 89.52M | 87.23M | 83.59M | 90.39M |
| Total Equity | 87.74M | 78.38M | 70.29M | 74.66M | 73.85M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 311.64M | 247.27M | 132.79M | 164.7M | 164.24M |
| Total Liabilities | 149.37M | 169.02M | 153.93M | 76.96M | 90.39M |
| Total Equity | 162.27M | 78.24M | -21.15M | 87.74M | 73.85M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -128.51M | -29.7M | -47.89M | -54.78M | -46.91M |
| Investing | -50.09M | 21.39M | 31.94M | 36.87M | 51.78M |
| Financing | 135.34M | 13.19M | 13.91M | 15.09M | 15.97M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -48.73M | -77.31M | -70.3M | -128.51M | -46.91M |
| Investing | -69.72M | 56.93M | 79.7M | -50.09M | 51.78M |
| Financing | 179.68M | 263k | 14.54M | 135.34M | 15.97M |
| Market Cap | 792.36M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 96.63M |
| Average Volume (1 week) | 751.25k |
| Average Volume (1 Month) | 1.18M |
| 52 Week Change | -52.38% |
| 52 Week High | 19.09 |
| 52 Week Low | 7.39 |
| Spread (Intraday) | 1.14 (12.82%) |
| Company Name | Avadel Pharmaceuticals PLC |
| Address |
10 earlsfort terrace dublin D02 T380 |
| Website | https://www.avadel.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
